PMID: 16639181Apr 28, 2006Paper

Pharmacogenetics in mood disorder.

Current Opinion in Psychiatry
Charles U NnadiAnil K Malhotra

Abstract

Not all patients with mood disorder respond well to drug treatment. Emerging data suggest that genetic mechanisms could be involved. We searched the literature database and highlighted recent molecular genetic studies pertaining to drug response in mood disorders. Recent pharmacogenetic studies in mood disorders have reported generally positive findings supporting the view that genotyping may improve the confidence of prospectively identifying treatment response and adverse outcomes. The evidence documenting genotype-based response to drug treatment is rapidly expanding. Genes encoding target receptors and signal transduction systems may predict the efficacy of drug therapy in mood disorders. Additional predictors of treatment response in bipolar disorder may include the immediate early genes, mitochondrial genes and epigenetic mechanisms, although some of these studies are still preliminary.

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Related Papers

Reviews of Physiology, Biochemistry and Pharmacology
P Propping
Therapie der Gegenwart
G Jörgensen
Pharmazie in unserer Zeit
G Jörgensen
The Practitioner
M E Pembrey
© 2022 Meta ULC. All rights reserved